Description

Semax was originally developed back in Russia to prevent and treat circulatory disorders. It has also been identified as a “nootropic” or “cognitive enhancer.” This is a synthetic peptide drug developed based on the molecular structure of adrenocorticotropic hormone (ACTH). Back in Russia, Semax was initially used to treat strokes and brain damage. This drug has also been reported to have interesting effects on animal models, reducing stress, and enhancing memory performance. Inject 0.3-1 mL subcutaneously twice a week. This will also depend on the patient’s response.